Rebel's Edge with Jon & Pete Najarian

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Eli Lilly reaping insulin profits, 3M approaching 52-week highs, PayPal outperforming sector peers, and Chegg struggling to catch up in the AI game. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the 2025 NFL draft, and looking at SuperBowl odds with Draft Kings. Stay on the cutting edge with Rebel's Edge.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Elon Musk clearing the way for Tesla growth in China, Domino's Pizza boosting customer loyalty, Philips settling a major class action lawsuit, and Soleno Therapeutics scoring a "Breakthrough Therapy Designation" for their new treatment. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about Anthony Edwards with the Timberwolves, and the best and worst of the NFL draft. Stay on the cutting edge with Rebel's Edge.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Meta and IBM both tanking hard, Southwest Airlines still struggling with Boeing blowback, and Caterpillar falling on decreased revenue. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about NFL draft sleeper schools and NFL draft ratings. Stay on the cutting edge with Rebel's Edge.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Tesla announcing new models, Texas Instruments with an optimistic outlook, Enphase Energy with a big miss, and Vertiv spiking on strong outlook. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the Timberwolves and sports gambling. Stay on the cutting edge with Rebel's Edge.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Salesforce cooling talks to acquire Informatica, Bitcoin stocks continuing to do well, CoStar acquiring Matterport, and Cardinal Health losing a key distribution deal. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the NFL draft and the Vikings chances of bringing back Tom Brady. Stay on the cutting edge with Rebel's Edge.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Alaska Airlines spiking on strong guidance, eBay making Morgan Stanley analysts swoon with their AI adoption, Lithium Americas Corp making moves with GM, and D.R. Horton with a big beat. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about Dion Sanders losing players to the portal, and an NFL mock draft. Stay on the cutting edge with Rebel's Edge.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including United Airlines beating estimates, Vanda Pharmaceutical fielding a buyout offer, J.B. Hunt missing on earnings, and ASML with a big miss. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about paying Olympic athletes and the NHL's record setting season. Stay on the cutting edge with Rebel's Edge.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Apple losing the top smartphone spot to Samsung, Live Nation facing an antitrust lawsuit, Morgan Stanley posting a good quarter, and Intra-Cellular Therapies seeing encouraging phase 3 results. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the Masters ratings and Tom Brady teasing a return to the field. Stay on the cutting edge with Rebel's Edge.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Goldman Sach's surging profits, Encore Wire getting bought out, Medical Properties Trust unloading some hospitals, and Neumora Therapeutics having a phase 1 trial halted by the FDA. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the Masters ratings and Tom Brady teasing a return to the field. Stay on the cutting edge with Rebel's Edge.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Delta Airlines beating on earnings, Hexcel surprising Wall Street with a new CEO announcement, Google announcing a new ARM-based CPU to bolster its AI game, and the Consumer Discretionary reaction to inflation. dipping after a dismal earnings report. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about The Vikings draft prospects and MLB payrolls. Stay on the cutting edge with Rebel's Edge.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.